The FDA's drug regulatory arm is purely corrupt. It is structured as a development-to-market pipeline for its beneficiaries in the pharmaceutical industry. Well-tested generics like fluvoxamine are blocked because they don't fit the business model. Killing how many?
— CovidDataQuest (@covid_quest) May 26, 2022
Thursday, May 26, 2022
FDA: structured as a development-to-market pipeline for its beneficiaries. Well-tested generics like fluvoxamine are blocked because they don't fit the business model
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment